Award
National Cancer Institute 1K08CA304477-01A1
Alleviating early immune suppression after radiotherapy
Recipient
University of Chicago
Award Amount
$178,723.00
Ceiling
$178,723.00
Awarded
July 14, 2026
Identifier
1K08CA304477-01A1
This award funds a research project aimed at understanding and alleviating early immune suppression caused by radiotherapy in cancer treatment, specifically targeting IL-4 mediated pathways to enhance anti-cancer effects and improve patient survival.
Description
Research project focusing on identifying and targeting the earliest mediators of immune suppression after radiotherapy to improve cancer treatment outcomes. The project investigates the role of IL-4 in immune suppression post-radiotherapy using human and mouse cancer models and advanced proteo-transcriptomic and immunological techniques.